WG
ZSAN

Winton Group’s Zosano Pharma Corporation ZSAN Stock Holding History

Winton Group’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,845
Closed -$80K – 1549
2021
Q1 		$80K Sell
1,845
-66
-3% -$2.76K ﹤0.01% 1342
2020
Q4 		$35K Sell
1,911
-1,523
-44% -$29.8K ﹤0.01% 1295
2020
Q3 		$195K Buy
3,434
+2,796
+438% +$130K 0.01% 1351
2020
Q2 		$19K Buy
+638
New +$18K ﹤0.01% 1426
2020
Q1 		– Sell
-292
Closed -$16K – 1593
2019
Q4 		$16K Sell
292
-1,182
-80% -$72.9K ﹤0.01% 1514
2019
Q3 		$80K Buy
+1,474
New +$132K ﹤0.01% 1477

Other funds holding ZSAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TI
Telemetry Investments New York $42.8M AUM 0.06% 1-Year Est. Return